Live Ownership Coverage: 0.5 is Centex Development Co LP’s (TSE:CTX) Institutional Investor Sentiment

November 22, 2016 - By Clifton Ray   ·   0 Comments

Live Ownership Coverage: 0.5 is Centex Development Co LP's (TSE:CTX) Institutional Investor Sentiment

Sentiment for Centex Development Co LP (TSE:CTX)

Centex Development Co LP (TSE:CTX) institutional sentiment decreased to 0.5 in 2016 Q2. Its down -1.00, from 1.5 in 2016Q1. The ratio has worsened, as 3 investment managers increased or started new equity positions, while 2 cut down and sold their holdings in Centex Development Co LP. The investment managers in our partner’s database now have: 430,175 shares, up from 292,372 shares in 2016Q1. Also, the number of investment managers holding Centex Development Co LP in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 2 Increased: 2 New Position: 1.

Crescita Therapeutics Inc. is a drug development company. The company has a market cap of $18.96 million. The Firm owns products for treating medical conditions in dermatology and pain. It currently has negative earnings. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin.

It is down 6.00% since October 23, 2016 and is uptrending. It has outperformed by 1.44% the S&P500.

Roosevelt Investment Group Inc holds 0.54% of its portfolio in Crescita Therapeutics Inc for 266,931 shares. Kcm Investment Advisors Llc owns 56,090 shares or 0.1% of their US portfolio. Moreover, Hancock Holding Co has 0.01% invested in the company for 13,141 shares. The Iowa-based Iowa State Bank has invested 0.01% in the stock. Massmutual Trust Co Fsb Adv, a Connecticut-based fund reported 81,150 shares.#img1#

CTX Company Profile

Qwest Corporation, incorporated on July 17, 1911, is a communications company. The Firm is engaged in providing an array of communications services to its residential, business, governmental and wholesale customers. The Company’s communications services include local voice, Internet, private line (including special access), network access, Ethernet, information technology (IT), video, wireless and other ancillary services. In certain local and regional markets, the Company also provides local access and fiber transport services to competitive local exchange carriers (CLEC). The Firm offers its services in the 14-state region of Arizona, Colorado, Idaho, Iowa, Minnesota, Montana, Nebraska, New Mexico, North Dakota, Oregon, South Dakota, Utah, Washington and Wyoming. For certain services and products the Company provides telecommunications network to transport data and voice traffic, and for a range of internal communications functions, it uses portions of CenturyLink, Inc.’s telecommunications network to transport data and voice traffic.

More notable recent Crescita Therapeutics Inc (TSE:CTX) news were published by: Prnewswire.com which released: “Crescita Therapeuticsâ„¢ Inc. Announces Acquisition of INTEGA Skin Sciences” on September 01, 2016, also Prnewswire.com with their article: “Nuvo Research® Announces TSX Conditional Approval to List Crescita …” published on November 23, 2015, Prnewswire.com published: “Crescita Therapeuticsâ„¢ Inc. Provides Corporate Update” on March 07, 2016. More interesting news about Crescita Therapeutics Inc (TSE:CTX) were released by: Reuters.com and their article: “BRIEF-Strategic partner Intega Skin Sciences Inc,acquired by Crescita Ther…” published on September 01, 2016 as well as Prnewswire.com‘s news article titled: “Crescita Therapeutics(TM) Announces 2016 Third Quarter Results” with publication date: November 14, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>